Nebu-Flow secures additional $5.9 million to accelerate next generation respiratory pharmaceuticals
Apr 29, 2024•over 1 year ago
Amount Raised
$5.9 Million
GlasgowMedicalBiotechnologyHealth CareInvestors
Conduit Eis Impact FundAscensionSis VenturesForesight Wae TechnologyScottish EnterpriseScvc
Description
Nebu-Flow has secured an additional $5.9 million of investment to accelerate the next generation of inhaled drugs for patients with respiratory disorders. The funding round was led by SCVC, a leading UK-based venture capital firm, and supported by Scottish Enterprise, Foresight WAE Technology, SIS Ventures, Ascension, and Conduit EIS Impact Fund.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers